Xtant Medical Reports 2026 Annual Meeting Voting Results

What Happened
Xtant Medical Holdings, Inc. filed an 8-K reporting the results of its Annual Meeting of Stockholders held on August 7, 2026 (record date June 9, 2026). There were 140,262,960 shares outstanding; 104,456,998 shares (74.47%) were represented, constituting a quorum. All six board nominees were elected, the appointment of Grant Thornton LLP as independent auditor for 2026 was ratified, and the company’s advisory (non-binding) vote on executive compensation was approved.

Key Details

• Record date and attendance: 140,262,960 shares outstanding (June 9, 2026); 104,456,998 shares voted at the meeting (74.47%).
• Director elections (votes For / Withheld; broker non-votes = 23,783,663 for each director):
  • John K. Bakewell: 80,444,952 For / 228,383 Withheld
  • Jonn R. Beeson: 79,698,307 For / 975,028 Withheld
  • Sean E. Browne: 80,428,295 For / 245,040 Withheld
  • Abhinav Jain: 80,335,481 For / 337,854 Withheld
  • Tyler P. Lipschultz: 80,450,301 For / 223,034 Withheld
  • Stavros G. Vizirgianakis: 79,590,709 For / 1,082,626 Withheld
• Auditor ratification: Grant Thornton LLP ratified as independent registered public accounting firm for year ending Dec 31, 2026 — 104,245,812 For; 30,112 Against; 181,074 Abstentions.
• Advisory vote on executive compensation: Approved — 79,416,901 For; 1,030,090 Against; 226,344 Abstentions; broker non-votes 23,783,663.

Why It Matters
These results confirm board continuity and governance stability (all six nominees elected). Ratification of Grant Thornton provides continuity of the company’s auditor for 2026. The advisory approval of executive compensation signals shareholder support for the company’s pay practices, though the vote is non-binding. Large broker non-votes were recorded on certain matters, which can reflect shares held in street name where brokers lacked authority to vote.